Assessing the potential of skin electroporation for the delivery of protein- and gene-based drugs

Trends in Biotechnology

Volumn 16, Issue 10, 1998, Pages 408-412

  Banga, Ajay K ^a   Prausnitz, Mark R ^b  

^a AUBURN UNIVERSITY   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALNIDITAN; BLEOMYCIN; CALCEIN; DOMPERIDONE; ERYTHROSINE; FENTANYL; GONADORELIN; HEPARIN; LEUPRORELIN; METOPROLOL; OLIGONUCLEOTIDE; PEPTIDE; POLYSACCHARIDE;

CANCER; CANCER CHEMOTHERAPY; DRUG PENETRATION; ELECTROPORATION; GENE TARGETING; PRIORITY JOURNAL; SHORT SURVEY; SKIN PERMEABILITY; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0032440065     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-7799(98)01238-4     Document Type: Article

References (35)

1. Banga, A. K. (1998) Electrically assisted transdermal and topical drug delivery Taylor & Francis.
2. Banga, A. K. (1996) Therapeutic Peptides and Proteins: Formulation, Processing and Delivery Systems Technomic, Lancaster, PA, USA.
3. Prausnitz M. R., Bose V. G., Langer R., Weaver J. C. Proc. Natl. Acad. Sci. U. S. A. 90:1993;10504-10508.
4. Pliquett U., Weaver J. C. Bioelectrochem. Bioenerg. 39:1996;1-12.
5. Prausnitz M. R., Gimm J. A., Guy R. H., Langer R., Weaver J. C., Cullander C. J. Pharm. Sci. 85:1996;1363-1370.
6. Edwards D. A., Prausnitz M. R., Langer R., Weaver J. C. J. Control. Release. 34:1995;211-221.
7. Prausnitz M. R. J. Control. Release. 40:1996;321-326.
8. Vanbever R., LeBoulenge E., Preat V. Pharm. Res. 13:1996;559-565.
9. Vanbever R., Lecouturier N., Preat V. Pharm. Res. 11:1994;1657-1662.
10. Hofmann G. A., Rustrum W. V., Suder K. S. Bioelectrochem. Bioenerg. 38:1995;209-222.
11. Zhang L., Li L. N., An Z. L., Hoffman R. M., Hofmann G. A. Bioelectrochem. Bioenerg. 42:1997;283-292.
12. Zhang L., Hofmann G. A. Proc. Int. Symp. Control. Release Bioact. Mater. 24:1997;27-28.
13. Prausnitz M. R., Pliquett U., Langer R., Weaver J. C. Pharm. Res. 11:1994;1834-1837.
14. Pliquett U., Weaver J. C. J. Control. Release. 38:1996;1-10.
15. Kost J., Pliquett U., Mitragotri S., Yamamoto A., Langer R., Weaver J. Pharm. Res. 13:1996;633-638.
16. Belehradek M., Domenge C., Luboinski B., Orlowski S., Belehradek J., Mir L. M. Cancer. 72:1993;3694-3700.
17. Dev S. B., Hofmann G. A. Cancer Treat. Rev. 20:1994;105-115.
18. Heller R.et al. Cancer. 77:1996;964-971.
19. Jaroszeski M. J., Gilbert R., Heller R. Adv. Drug Deliv. Rev. 26:1997;185-197.
20. Heller R., Jaroszeski M., Perrott R., Messina J., Gilbert R. Melanoma Res. 7:1997;10-18.
21. Jaroszeski M. J., Gilbert R., Perrott R., Heller R. Melanoma Res. 6:1996;427-433.
22. Bommannan D. B., Tamada J., Leung L., Potts R.O. Pharm. Res. 11:1994;1809-1814.
23. Riviere J. E., Monteiro-Riviere N. A., Rogers R. A., Bommannan D., Tamada J. A., Potts R. O. J. Control. Release. 36:1995;229-233.
24. Wang S., Kara M., Krishnan T. R. Drug Dev. Ind. Pharm. 23:1997;657-663.
25. Prausnitz M. R., Edelman E. R., Gimm J. A., Langer R., Weaver J. C. Biotechnology. 13:1995;1205-1209.
26. Weaver J. C., Vanbever R., Vaughan T. E., Prausnitz M. R. Biochem. Biophys. Res. Commun. 234:1997;637-640.
27. Vanbever R., Prausnitz M. R., Preat V. Pharm. Res. 14:1997;638-644.
28. Zewert T. E., Pliquett U. F., Langer R., Weaver J. C. Biochem. Biophys. Res. Commun. 212:1995;286-292.
29. Regnier V., Tahiri A., Andre N., Lamaitre M., Preat V., Doan T. L. Pharm. Res. 14:1997;S-640.
30. Treco D. A., Selden R. F. Mol. Med. Today. 1:1995;314-321.
31. Zhang L., Li L. N., Hoffmann G. A., Hoffman R. M. Biochem. Biophys. Res. Commun. 220:1996;633-636.
32. Titomirov A. V., Sukharev S., Kistanova E. Biochim. Biophys. Acta. 1088:1991;131-134.
33. Shaw K. Pharm. Times. July:1997;38-41.
34. Vanbever, R., Fouchard, D., Jodoul, A., De Morre, N., Preat, V. and Marty, J. P. Skin Pharmacol. (in press).
35. Prausnitz M. R. Adv. Drug Deliv. Rev. 18:1996;395-425.